###begin article-title 0
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
Resequencing PNMT in European hypertensive and normotensive individuals: no common susceptibilily variants for hypertension and purifying selection on intron 1
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 141 145 141 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human linkage and animal QTL studies have indicated the contribution of genes on Chr17 into blood pressure regulation. One candidate gene is PNMT, coding for phenylethanolamine-N-methyltransferase, catalyzing the synthesis of epinephrine from norepinephrine.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 312 322 312 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In silico </italic>
Fine-scale variation of PNMT was screened by resequencing hypertensive (n = 50) and normotensive (n = 50) individuals from two European populations (Estonians and Czechs). The resulting polymorphism data were analyzed by statistical genetics methods using Genepop 3.4, PHASE 2.1 and DnaSP 4.0 software programs. In silico prediction of transcription factor binding sites for intron 1 was performed with MatInspector 2.2 software.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 503 508 503 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 763 773 763 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In silico </italic>
###xml 785 790 785 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 904 907 904 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 1189 1194 1189 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 358 366 <span type="species:ncbi:9606">patients</span>
###xml 827 832 <span type="species:ncbi:9606">human</span>
PNMT was characterized by minimum variation and excess of rare SNPs in both normo- and hypertensive individuals. None of the SNPs showed significant differences in allelic frequencies among population samples, as well as between screened hypertensives and normotensives. In the joint case-control analysis of the Estonian and the Czech samples, hypertension patients had a significant excess of heterozygotes for two promoter region polymorphisms (SNP-184; SNP-390). The identified variation pattern of PNMT reflects the effect of purifying selection consistent with an important role of PNMT-synthesized epinephrine in the regulation of cardiovascular and metabolic functions, and as a CNS neurotransmitter. A striking feature is the lack of intronic variation. In silico analysis of PNMT intron 1 confirmed the presence of a human-specific putative Glucocorticoid Responsive Element (GRE), inserted by Alu-mediated transfer. Further analysis of intron 1 supported the possible existence of a full Glucocorticoid Responsive Unit (GRU) predicted to consist of multiple gene regulatory elements known to cooperate with GRE in driving transcription. The role of these elements in regulating PNMT expression patterns and thus determining the dynamics of the synthesis of epinephrine is still to be studied.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
We suggest that the differences in PNMT expression between normotensives and hypertensives are not determined by the polymorphisms in this gene, but rather by the interplay of gene expression regulators, which may vary among individuals. Understanding the determinants of PNMT expression may assist in developing PNMT inhibitors as potential novel therapeutics.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 208 209 208 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 303 304 303 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 482 483 482 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 484 485 484 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 722 723 722 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 724 725 724 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 987 995 987 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PRKWNK4 </italic>
###xml 1048 1049 1048 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 212 217 <span type="species:ncbi:9606">Human</span>
###xml 367 371 <span type="species:ncbi:10116">rats</span>
###xml 415 420 <span type="species:ncbi:9606">human</span>
###xml 664 669 <span type="species:ncbi:9606">human</span>
Hypertension is a critical risk factor for cardiovascular disease. Estimates from the studies of familiar aggregation indicate that approximately 30% of blood pressure variance is due to a genetic component [1]. Human Chr17 harbors genes possibly playing an important role in blood pressure regulation [2]. Multiple evidence from the genetic analysis of hypertensive rats indicates that genes on Chr10, syntenic to human Chr17, might be implicated in the aetiology of hypertension [3,4]. Consistently, there is a group of markers at an interval 60-67 cM from the proximal telomere on Chr17, that has been reported to demonstrate significant evidence of linkage in human families with clustering of essential hypertension [2,4]. Furthermore, for four pseudohypoaldosteronism type II (PHAII; Gordon's syndrome) pedigrees characterized by Mendelian inheritance of the disease, four different mutations, possibly leading to increased salt reabsorption and intravascular volume were found in PRKWNK4 (WNK lysine deficient protein kinase 4) at 17q21-22 [5].
###end p 11
###begin p 12
###xml 31 34 31 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACE</italic>
###xml 188 192 188 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACE </italic>
###xml 241 245 241 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACE </italic>
###xml 296 297 296 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 355 359 355 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT</italic>
###xml 794 795 794 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1014 1015 1014 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1162 1163 1162 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1166 1171 1166 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pnmt </italic>
###xml 1346 1347 1346 1347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1393 1398 1393 1398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pnmt </italic>
###xml 1551 1553 1551 1553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1565 1570 1565 1570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pnmt </italic>
###xml 1707 1709 1707 1709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1755 1760 1755 1760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 1806 1811 1806 1811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 1817 1819 1817 1819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1820 1822 1820 1822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1977 1982 1977 1982 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 2140 2144 2140 2144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT</italic>
###xml 2259 2261 2259 2261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 2308 2313 2308 2313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 2549 2559 2549 2559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
###xml 2611 2616 2611 2616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 2662 2667 2662 2667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 475 480 <span type="species:ncbi:9606">human</span>
###xml 789 792 <span type="species:ncbi:10116">rat</span>
###xml 801 806 <span type="species:ncbi:9606">human</span>
###xml 945 953 <span type="species:ncbi:9606">patients</span>
###xml 1150 1154 <span type="species:ncbi:10116">rats</span>
###xml 1156 1159 <span type="species:ncbi:10116">SHR</span>
###xml 1248 1251 <span type="species:ncbi:10116">SHR</span>
###xml 1389 1392 <span type="species:ncbi:10116">rat</span>
###xml 1498 1501 <span type="species:ncbi:10116">rat</span>
###xml 1540 1543 <span type="species:ncbi:10116">rat</span>
###xml 1686 1689 <span type="species:ncbi:10116">rat</span>
###xml 1691 1697 <span type="species:ncbi:9913">bovine</span>
###xml 1749 1754 <span type="species:ncbi:9606">human</span>
###xml 1800 1805 <span type="species:ncbi:9606">human</span>
###xml 2302 2307 <span type="species:ncbi:9606">human</span>
###xml 2605 2610 <span type="species:ncbi:9606">human</span>
Angiotensin Converting Enzyme (ACE) is the only Chr17 candidate gene investigated in detail for the role in the aetiology of essential hypertension. Still, association studies targeted to ACE polymorphisms are inconsistent about the role of ACE variants providing susceptibility to hypertension [1]. Another functionally relevant candidate at 17q21-22 is PNMT, coding for phenylethanolamine-N-methyltransferase, which has, however, attracted less attention as an affecter of human blood pressure. PNMT catalyzes the synthesis of epinephrine from norepinephrine, the last step of catecholamine biosynthesis. Although, it is mainly expressed in neuroendocrine chromaffin cells in the adrenal medulla, extraadrenal PNMT has been suggested to be involved in the development of hypertension in rat [6]. In human phaeochromocytomas, catecholamine-producing neuroendocrine tumours arising from chromaffin cells or extra-adrenal paraganglian, 50-60% of patients suffer from sustained and 30% from paroxysmal hypertension [7]. Inhibitors of PNMT reduce its activity in the brainstem and have reported to lower blood pressure in the spontaneously hypertensive rats (SHR) [8]. Pnmt mRNA expression in Central Nervous System (CNS) was significantly greater in SHR compared to normotensive strains, and was positively correlated with systolic blood pressure [9]. However, comparative sequencing of the rat Pnmt coding regions has revealed no sequence differences between stroke-prone spontaneously hypertensive rat (SHRSP) and normotensive Wistar-Kyoto rat genes [10]. Although Pnmt expression, its regulation, and involvement in blood pressure maintenance have been intensively studied for animal (rat, bovine) models [11], there is a scarce of knowledge about human PNMT gene. The early works on cloning of the human PNMT gene [12,13] revealed that two types of mRNA transcripts are produced through the use of alternative promoters. To our knowledge the only published study focusing on PNMT gene and hypertension investigated the role of two 5'upstream Single Nucleotide Polymorphisms (SNPs) and reported a significant enrichment of the G-allele of PNMT-390 promoter variant for hypertensive African Americans, but not for the Greeks and Americans of European decent [14]. We aimed (1) to resequence the entire human PNMT gene in hypertensive and normotensive individuals of European origin in order to uncover the fine-scale sequence variation and to identify novel hypertension-susceptibility polymorphisms; (2) to apply population genetics statistics and in silico methods to trace the evolutionary pressure on human PNMT and to explore a gene regulatory potential of PNMT first intron reflecting the effect of purifying selection.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
DNA samples of hypertensive and normotensive individuals
###end title 14
###begin p 15
###xml 833 836 833 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink">nd </sup>
###xml 1022 1024 1022 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 55 60 <span type="species:ncbi:9606">Human</span>
###xml 970 978 <span type="species:ncbi:9606">patients</span>
The study has been approved by the Ethics Committee on Human Research of University of Tartu, Estonia (permission no 122/13,22.12.2003). All recruited individuals gave their informed consent prior to their inclusion in the study. Diagnosis and classification of hypertension was carried out by "Practice Guidelines for primary care physicians: 2003 ESH/ESC hypertension Guidelines" Journal of Hypertension 21(10)" pp. 1779-1786. Estonian individuals with primary hypertension (n = 25) were recruited into the study by blood pressure specialists (cardiologist M.V.; nephrologist M.O.) during their ambulatory visit or hospitalization in the Cardiology and Internal Medicine Clinics at the Tartu University Hospital, Estonia. Czech individuals with essential hypertension (n = 25) were recruited from the Cardiology Department of the 2nd Clinic of Internal Medicine, Faculty Hospital Kralovske Vinohrady in Prague (coordinated by V.K.). Details of the collection of Czech patients and normotensives are published elsewhere [15]. The criteria for the selection of hypertensive individuals for the study:
###end p 15
###begin p 16
1. Hypertension diagnosed by a specialist (cardiologist, nephrologist)
###end p 16
###begin p 17
2. Grade 2 or severe hypertension at diagnosis (systolic blood pressure, SBP >160 mmHg; diastolic blood pressure, DBP >100 mmHg)
###end p 17
###begin p 18
###xml 24 27 <span type="species:ncbi:9606">men</span>
###xml 38 43 <span type="species:ncbi:9606">women</span>
3. Age at diagnosis for men </=55 and women </=65 years (to exclude secondary, age-related hypertension)
###end p 18
###begin p 19
4. Exclusion of secondary causes for hypertension (such as diabetes, primary renal failure) by a specialist clinician
###end p 19
###begin p 20
5. Family background of high blood pressure (to maximize genetic susceptibility)
###end p 20
###begin p 21
###xml 35 38 35 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">st </sup>
###xml 130 133 130 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">nd </sup>
###xml 110 118 <span type="species:ncbi:9606">patients</span>
###xml 330 338 <span type="species:ncbi:9606">patients</span>
Hypertension was documented among 1st degree relatives for 84% (n = 21) of Estonian and 92% (n = 23) of Czech patients and among 2nd degree relatives for 28% (n = 7) of Estonian hypertensives (for Czech: data not available). Multiple hypertensive family members were reported for 36% (n = 9) of Estonian and 48% (n = 12) of Czech patients.
###end p 21
###begin p 22
6. All recruited individuals received antihypertensive treatment prescribed by a specialist. Blood pressure measurements under antihypertensive therapy were documented: SBP mean 142.8 and range 115 - 215 mmHg; DBP mean 88.4 and range 80-105 mmHg).
###end p 22
###begin p 23
###xml 201 206 201 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 97 105 <span type="species:ncbi:9606">patients</span>
###xml 270 278 <span type="species:ncbi:9606">patients</span>
A classical case-control study maximizes its power by sampling a clinically homogeneous group of patients. The aim of our resequencing and mutation screening study was to obtain exhaustive coverage of PNMT variation in hypertensives. Thus, a high proportion of included patients (Estonians 56%; Czech 92%) exhibited a spectrum of heterogeneous high-blood pressure related organ complications (MI, CAD, stroke, end-stage renal disease).
###end p 23
###begin p 24
Normotensives (age at recruitment >35 years) exhibited age-adjusted normal blood pressure based on repeated measurements, lack of family history of essential hypertension, absence of organ damages and had never been prescribed antihypertensive medication. Estonian normotensives (n = 25) were recruited in collaboration with Estonian Blood Centers across Estonia, including only long-term blood donors exhibiting optimal (<120/<80 mmHg)/normal (120-129/80-84 mmHg) blood pressure. Hypertensive and normotensive groups did not differ in Body Mass Index (BMI), a risk factor for hypertension (Mann-Whitney U-test; p > 0.05, two-tailed). BMI ranged for Estonian hypertensives 28.7 +/- 6.3, and normotensives 25.2 +/- 3.0; and for Czech hypertensives 26 +/- 2.3, and normotensives 24.6 +/- 2.5.
###end p 24
###begin title 25
###xml 18 23 <span type="species:ncbi:9606">human</span>
Re-sequencing the human PNMT gene
###end title 25
###begin p 26
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 125 130 125 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 137 138 137 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 719 721 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 16 21 <span type="species:ncbi:9606">human</span>
The sequence of human PNMT gene [GenBank:] has been obtained from NCBI GenBank database [16]. PCR and sequencing primers for PNMT (Table 1) were designed using the web-based Primer3 software [17]. The uniqueness of all the primers was checked using BLAST [18]. The PCR primers were designed to cover the entire coding region and parts of 5' and 3' UnTranslated Regions (UTR) (3148 bp); and amplify two overlapping PCR fragments, 1846 bp and 1842 bp respectively. Amplification was performed with 100 ng genomic DNA using Long PCR Enzyme Mix (MBI Fermentas). Conditions for PCR amplifications, product purification, sequencing, sequence contig assembly and polymorphism identification are described in detail elsewhere [19].
###end p 26
###begin p 27
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 31 36 <span type="species:ncbi:9606">human</span>
PCR and sequencing primers for human PNMT gene
###end p 27
###begin title 28
Data analysis
###end title 28
###begin p 29
###xml 363 365 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 464 466 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
Testing of Hardy-Weinberg equilibrium (alpha = 0.05); estimation of allele and genotype frequencies of identified Single Nucleotide Polymorphisms (SNPs); and comparison of allelic/genotypic as well as promoter haplotype distribution between hypertensives and normotensives (Fisher's exact test; alpha = 0.05) were implemented with Genepop software (Version 3.4) [20]. Promoter haplotypes were predicted by the Bayesian statistical method in the program PHASE 2.1 [21].
###end p 29
###begin p 30
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 413 415 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 585 586 580 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 589 591 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 654 659 649 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 726 728 721 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T </sup>
###xml 833 835 818 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T </sup>
###xml 876 878 861 863 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T </sup>
###xml 1039 1041 1024 1026 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T </sup>
###xml 1200 1202 1185 1187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T </sup>
###xml 648 653 <span type="species:ncbi:9606">human</span>
Sequence diversity parameters were calculated by DnaSP software (Version 4.0) [22]. Nucleotide diversity provides a measure of genetic variation that is normalized by the number of sampled chromosomes. We calculated two conventional measures of nucleotide diversity: (i) pi, the direct estimate of per-site heterozygosity derived from the observed average pairwise sequence difference and (ii) Watterson's theta [23], the population mutation parameter representing an estimate of the expected per-site heterozygosity based on the number of segregating site (S). Tajima's D statistic (DT) [24] was calculated to determine if the observed pattern of human PNMT gene diversity is consistent with the standard neutral model. The DT value is the difference between pi and theta estimates. In case of neutrality pi equals theta, and thus DT statistic equals zero. The direction of DT statistics (either <0 or >0) is potentially informative about the evolutionary and demographic forces that the population has experienced. Significant positive DT values indicate an excess of intermediate-frequency alleles consistent with either balancing selection or population bottleneck, whereas significant negative DT values indicate an excess of rare SNPs consistent with either recent directional selection or an increase in population size.
###end p 30
###begin p 31
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In silico </italic>
###xml 70 75 70 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
In silico prediction of transcription factor-binding sites (TFBS) for PNMT intron 1 was carried out by MatInspector 2.2 [25,26] online software. The program identifies TFBS in nucleotide sequences using large library of position weight matrices (PWM) and is based on the information about experimentally defined TFBSs collected in the TRANSFAC database [27]. The presence of repetitive sequences was analyzed by RepeatMasker online software [28].
###end p 31
###begin title 32
Results
###end title 32
###begin title 33
###xml 16 21 <span type="species:ncbi:9606">human</span>
Resequencing of human PNMT reveals low diversity
###end title 33
###begin p 34
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 416 421 416 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 626 627 626 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 636 637 636 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 800 802 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 897 902 896 901 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 1073 1074 1071 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 19 24 <span type="species:ncbi:9606">human</span>
We resequenced the human PNMT genomic sequence (in total 3187 bp) in hypertensive (n = 50) and normotensive (n = 50) individuals originating from two European populations. The analyzed region (from -882 to +2305 relative to ATG) included the entire 5' and 3'UTR regions, three exons (424 bp, 208 bp and 525 bp respectively) and two introns. The identified diversity patterns supported the conservative nature of the PNMT gene. We determined only three rare genic polymorphisms; in contrast, the upstream region harboured four SNPs, two of which (SNP -184 A/G; SNP -390 A/G) are previously characterized common variants (Table 2, Figure 1). Majority of the SNPs were identified in both populations and none was exclusively present in only hypertensive individuals. Compared to a data set of 74 genes [29], characterized by a mean nucleotide diversity parameter pi = 0.00080 for European Americans, PNMT gene exhibited approximately three times lower diversity among studied populations including both normotensive and hypertensive individuals (pi = 0.00026 - 0.00032; Table 3). As the only identified non-synonymous mutation (Exon 3; SNP +1517; Ala->Thr) was present in both populations for individuals with normal (Major Allele Frequency, MAF = 6%) as well as elevated (MAF = 4%) blood pressure, we exclude this protein variant increasing susceptibility for hypertension.
###end p 34
###begin p 35
Allele (major) and genotype (major homozygote, heterozygote) frequencies for identified SNPs by resequencing in Estonian and Czech normotensives and hypertensives
###end p 35
###begin p 36
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 27 28 27 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
alocation relative to ATG; bmajor allele frequency; NA-not available
###end p 36
###begin p 37
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 17 22 <span type="species:ncbi:9606">human</span>
The structure of human PNMT gene drawn to an approximate scale. The identified SNPs (major allele by capital letters) are located relative to translation start site (ATG), where A denotes +1. SNPs with minor allele frequency <10% are indicated with short bars and >10% with long bars. Variants detected both in Estonians and Czech are shown in black; only in Czech are in grey and only in Estonians in white. The SNPs above and below the graph represent polymorphisms found in hypertensive and normotensive individuals, respectively. The 5'and 3'UTR have been indicated according to NCBI GenBank database (February 28, 2006 release).
###end p 37
###begin p 38
###xml 570 571 570 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 525 533 <span type="species:ncbi:9606">patients</span>
When we addressed the population differentiation of the identified SNPs by Fisher's exact test, none of the polymorphisms showed either allelic or genotypic differentiation among the Estonians and the Czech, as well as between normotensive and hypertensive individuals in the intrapopulation comparisons (p > 0.05, data not shown). The joint case-control analysis of all samples with an increased test power detected a significant excess of heterozygotes for common promoter region polymorphisms (SNP-184; SNP-390) among the patients (Fisher exact test, p < 0.05; Table 2). There was a non-significant difference between normotensives and hypertensives for the distribution of haplotypes formed from two common 5'UTR polymorphisms, SNP -390 and SNP -184.
###end p 38
###begin p 39
###xml 124 125 124 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 233 240 232 239 <sub xmlns:xlink="http://www.w3.org/1999/xlink">intron </sub>
###xml 263 274 261 272 <sub xmlns:xlink="http://www.w3.org/1999/xlink">5'upstream </sub>
###xml 299 300 297 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 355 360 352 357 <sub xmlns:xlink="http://www.w3.org/1999/xlink">exon </sub>
###xml 663 664 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
However, the most striking feature of PNMT gene is the lack of variation within introns harboring only one rare SNP (Figure 1; intron 1, SNP+360). The introns exhibit >15-fold less diversity compared to analyzed 5'upstream region (piintron = 0.00002 - 0.00007; pi5'upstream = 0.00099-0.00138; Table 3) and >7-fold reduction in diversity compared exons (piexon = 0.00050-0.00056). In comparison, the excess of diversity for the 5'upstream region compared to the exons is only 2-2.5 times. To test whether patterns of DNA sequence variation in PNMT fit the expectations under hypothesis of neutrality, we analyzed the data with the Tajima DT neutrality test (Table 3). When the analysis included an entire PNMT gene there was no difference between observed (pi) and expected (theta) nucleotide diversity parameters. Notably, intronic sequences formed an exception with the expected variation (theta = 0.00018-0.00021) exceeding the observed values (pi = 0.00002-0.00007) up to tenfold. Whereas the lack of diversity in intron 2 spanning only 114 bp is apparently due to functional constraint on neighboring exons, minimal variation and consistent Tajima DT values for intron 1 support an effect of purifying selection on this region.
###end p 39
###begin p 40
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 33 38 <span type="species:ncbi:9606">human</span>
Sequence diversity parameters of human PNMT gene region
###end p 40
###begin p 41
###xml 47 48 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 98 99 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 132 133 132 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 156 157 156 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
Estimate of nucleotide diversity per site from aaverage pairwise difference among individuals and bnumber of segregating sites (S); cTajima's D statistics; dn = 25 for normotensives, n = 25 for hypertensives; NA - not applicable
###end p 41
###begin p 42
###xml 19 24 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pnmt </italic>
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 292 297 292 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 301 306 301 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pnmt </italic>
###xml 316 322 316 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AluSp </italic>
###xml 372 373 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 418 422 418 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT</italic>
###xml 13 18 <span type="species:ncbi:9606">human</span>
###xml 28 31 <span type="species:ncbi:10116">rat</span>
###xml 235 240 <span type="species:ncbi:9606">human</span>
###xml 412 417 <span type="species:ncbi:9606">human</span>
Alignment of human PNMT and rat Pnmt gene reveals high level of exonic conservation (>82%) at the level of DNA sequence between two species (See additional file 1). In contrast to the expectations based on selection pressure shown for human intron 1, there is no homology between intron 1 of PNMT and Pnmt genes. An AluSp insertion in primate lineage (See additional file 1) has changed the genomic landscape of human PNMT.
###end p 42
###begin title 43
In silico analysis of PNMT intron 1 for putative binding sites of gene regulatory elements
###end title 43
###begin p 44
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 105 115 105 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 517 519 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 543 548 543 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 654 655 654 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 715 720 715 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pnmt </italic>
###xml 72 77 <span type="species:ncbi:9606">human</span>
###xml 711 714 <span type="species:ncbi:10116">rat</span>
In order to explore the hypothesis of the purifying selection acting on human PNMT intron 1, we analyzed in silico the distribution of functionally important putative regulatory elements in this region. Two seminal works [12,13] have predicted the presence of a Glucocorticoid Responsive Element (GRE) in the middle of intron 1. In a number of genes, the glucocorticoid (GC) response is enhanced by the binding of other transcription factors to adjacent binding sites, forming Glucocorticoid Responsive Units (GRUs) [30]. We explored putative PNMT regulatory elements among the predicted transcription factor binding sites (TFBS) within intron 1 (Figure 2). We focused on TFBS-s either reported (1) to regulate rat Pnmt gene; (2) to form active GRUs; (3) to locate within intronic gene regulatory units; or (4) selected as potential inducers/repressors of epinephrine synthesis.
###end p 44
###begin p 45
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 269 274 269 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 463 469 463 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AluSp </italic>
###xml 67 72 <span type="species:ncbi:9606">human</span>
###xml 448 453 <span type="species:ncbi:9606">human</span>
Identification of putative transciption regulating elements within human PNMT intron 1. Putative transcription factors binding sites (TFBS) predicted by MatInspector 2.2 software and regulatory elements identified by manual inspection are depicted upon the sequence of PNMT intron 1 (951 bp). The Glucocorticoid Responsive Element (GRE; consensus GGTACAnnnTGTTCT), a core for a potential Glucocorticoid Responsive Unit (GRU), is given in bold. The human-specific AluSp element is underlined. The two-directional arrows indicate the predicted binding sites for regulatory factors: IRE - Insulin Responsive Element (consensus T(G/A)TTT(T/G)(G/T)); ERE - Estrogen Responsive Element (consensus GGTCAnnnTGACC); NFkappaB - Nuclear Factor kappa B; Sp1/2 - Specificity protein 1/2; Egr1 - Early Growth Response 1; MAZ - Myc-Associated Zinc finger protein; ZBP-89 - Zinc finger Binding Protein 148, ZNF148; HMGI/Y - High Mobility Group protein isoform I and Y, HMGA1; RORA (RORalpha) - Retinoic acid receptor-related Orphan Receptor alpha; E4BP4 - mammalian transcription factor E4 Binding Protein 4.
###end p 45
###begin p 46
###xml 8 13 8 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pnmt </italic>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 410 415 410 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 495 496 495 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 815 817 815 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1350 1352 1338 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 3 6 <span type="species:ncbi:10116">rat</span>
###xml 404 409 <span type="species:ncbi:9606">human</span>
###xml 692 698 <span type="species:ncbi:9913">bovine</span>
In rat, Pnmt transcription is synergistically activated by binding of Egr-1 (Early Growth Response 1), AP2 (Activating enhancer binding Protein 2 alpha) and GR (Glucocorticoid-activated Receptor complex) to the upstream promoter [31], whereas Sp1 (Specificity protein 1) and MAZ (Myc-Associated Zinc finger protein) transcription factors may potentially contribute to tissue-specific expression [32]. In human PNMT intron 1 we identified multiple binding sites for Egr1, MAZ and Sp1/Sp2 (Figure 2). A shared recognition site for Egr1/MAZ/Sp1 276 bp upstream GRE overlaps with a binding site for another zinc-finger nuclear protein - ZBP-89 (Zinc finger Binding Protein 148). For example, for bovine adrenodoxin gene expressed in adrenal cortex, Sp1/Sp3 confer and ZBP-89 represses basal transcriptional activities [33]. An alternative binding site for Sp1/Sp2 (74 bp downstream GRE) is co-localized with binding site for NFkappaB (Nuclear Factor kappa B), a transcription factor involved mainly in inflammatory and immune responses. There is an overlap also in the function of the two elements since GCs have potent anti-inflammatory and immunosuppressive properties. NFkappaB activity is antagonized by GCs either directly through inhibiting NFkappaB binding to DNA or indirectly by binding of the hormone-activated GC receptor complex (GR) to GRE [34].
###end p 46
###begin p 47
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 505 510 505 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 939 941 939 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1119 1121 1119 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 1006 1011 <span type="species:ncbi:9606">human</span>
###xml 1103 1108 <span type="species:ncbi:9606">human</span>
###xml 1113 1117 <span type="species:ncbi:10090">mice</span>
The most striking feature of human PNMT intron 1 is the abundance of predicted Insulin Responsive Elements [IRE, consensus sequence T(G/A)TTT(T/G)(G/T)]. GRE element is flanked both sides by multiple overlapping perfect IREs (four and two, respectively). Additional four IREs differing by one nucleotide from the consensus [T(G/A)TTT(T/G)C] are located in the vicinity. It has been shown that for a subset of genes insulin inhibits GR activity either via IRE-dependent or IRE-independent mechanisms [35]. PNMT intron 1 distal IREs overlap with a predicted binding site for HMGI/Y (High Mobility Group protein isoform I and Y), a mammalian architectural transcription factor that participates in specific protein-DNA and protein-protein interactions that induce both structural changes in chromatin substrates and the formation of stereospecific multiprotein complexes on the promoters/enhancers of genes whose transcription they regulate [36]. This factor is also part of nucleoprotein complex controlling human insulin receptor gene transcription and its loss causes insulin resistance and diabetes in human and mice [37].
###end p 47
###begin p 48
###xml 39 42 39 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 194 196 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 379 381 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 429 431 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 480 485 477 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 679 681 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 792 798 781 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E4BP4 </italic>
###xml 853 855 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 337 342 <span type="species:ncbi:9606">human</span>
Among the other reported GRU-belonging cis-acting elements, we identified (i) binding sites for Myc/Max family proteins, reported for the functional GRU of ovine beta1-adrenergic receptor gene [38]; (ii) two regions of overlapping putative GAGA-boxes shown to increase the rate of GRE-induced gene expression in the proximal enhancer of human carbamoylphosphate synthetase gene [39]; (iii) and Estrogen Responsive Element (ERE) [40]. Interestingly, ERE within the first intron of PNMT co-localizes with a binding site for RORA (Retinoic acid receptor-related Orphan Receptor alpha; also called RORalpha), reported among the key regulators of mammalian circadian gene expression [41]. Another putative 'clock controlled element', the binding site for a light-induced transcriptional repressor E4BP4 (mammalian transcription factor E4 Binding Protein 4) [42], was predicted within the cluster of IREs proximal to GRE.
###end p 48
###begin title 49
Discussion
###end title 49
###begin p 50
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 273 278 273 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 338 343 338 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pnmt </italic>
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 501 503 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 526 531 526 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 711 713 711 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 746 751 746 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 891 893 891 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 894 896 894 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 267 272 <span type="species:ncbi:9606">human</span>
###xml 334 337 <span type="species:ncbi:10116">rat</span>
###xml 573 578 <span type="species:ncbi:9606">human</span>
Resequencing revealed low variation of PNMT gene in both normotensive and hypertensive individuals consistent with an important role of PNMT-synthesized epinephrine in the regulation of cardiovascular and metabolic function and as a CNS neurotransmitter. Our data on human PNMT agrees with the report on comparative sequencing of the rat Pnmt in hypertensive SHRSP and normotensive strains [10] and allows to suggest that most of high between-subject variation in PNMT-synthesized epinephrine levels [43] does not result from PNMT gene variants. Indeed, the only described human PNMT allozyme displaying significantly lower levels of activity compared to wild-type, is a rare African-American variant Thr98Ala [44]. The expressional variation of PNMT gene is rather determined by the interplay of hormonal and neural stimuli as well as by the repertoire of regulating transcription factors [11,45].
###end p 50
###begin p 51
###xml 187 192 187 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 241 246 241 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GNMT </italic>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
Interestingly, the sequence parameters of the genomic region coding for the structurally and evolutionary most related enzyme to PNMT, the glycine-N-methyltransferase (GNMT) resemble the PNMT region [46]. Both genes have a similar size (the GNMT gene: 3.118 kb) and an exon-intron structure with a long first intron harbouring a SINE element; a low number of common SNPs, reduced diversity (NCBI dbSNP and International HAPMAP Project databases) and strong linkage disequilibrium. This supports the suggested evolutionary relationship between the two genes [46] as well as underlines the conserved role of N-methyltransferases in regulating essential metabolic functions.
###end p 51
###begin p 52
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pnmt </italic>
###xml 93 98 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 662 664 662 664 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 665 667 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 697 699 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 9 12 <span type="species:ncbi:10116">rat</span>
###xml 87 92 <span type="species:ncbi:9606">human</span>
Although rat Pnmt promoter has been characterized in detail, the regulatory regions of human PNMT gene have not been studied, with the exception of two common promoter SNPs. Consistent with a previous report [14], there was no significant difference in allele frequencies for SNP-184 and SNP-390 between European hyper- and normotensives. However, the heterozygote status of these promoter region polymorphisms was significantly associated with the diagnosis of hypertension. Interestingly, for neurological diseases such as Alzheimer disease and multiplex sclerosis, a protective effect of the heterozygous status of both SNPs (-390/-184 GA/AG) has been shown [47,48]. A recent functional study [44] using dual-luciferase assay has shown approximately 30% decrease in reporter gene activity for a construct carrying -390A/-184A haplotype (reported 50-60% frequency in Europeans) compared to -390G/-184G variant (60-70% in Africans).
###end p 52
###begin p 53
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 188 191 188 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 294 298 294 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu </italic>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 496 501 496 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 543 545 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 625 630 625 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 668 671 668 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Alu</italic>
###xml 705 710 705 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 868 873 868 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 967 998 967 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGFBP-1, TAT, AAT, PEPCK, PFK-2</italic>
###xml 1065 1067 1065 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1150 1155 1150 1155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pnmt </italic>
###xml 1423 1425 1423 1425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 1460 1465 1460 1465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 1550 1552 1550 1552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 1680 1682 1680 1682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 327 332 <span type="species:ncbi:9606">human</span>
###xml 522 525 <span type="species:ncbi:10116">rat</span>
###xml 535 541 <span type="species:ncbi:9913">bovine</span>
###xml 683 688 <span type="species:ncbi:9606">human</span>
###xml 1136 1139 <span type="species:ncbi:10116">rat</span>
###xml 1143 1149 <span type="species:ncbi:9913">bovine</span>
###xml 1304 1308 <span type="species:ncbi:10116">rats</span>
###xml 1454 1458 <span type="species:ncbi:10116">rats</span>
###xml 1585 1589 <span type="species:ncbi:10116">rats</span>
Intron 1 of human PNMT exhibits minimum diversity consistent with purifying selection. Two seminal works [12,13] predicted a putative GRE into this region, but due to a location within an Alu-sequence its functionality was questioned at that time [13]. Yet, there are several examples in which Alu sequences were inserted into human gene regions long time ago, were modified, and now are central in control/enhancement of transcription [49]. Glucocorticoid (GC) sensitivity has been reported for PNMT promoter activity in rat [31] and bovine [50], and at least one putative GRE has been identified for every species-specific PNMT gene. We explored a scenario that the Alu-introduced human-specific GRE in PNMT intron 1 has evolved to a functional GRU with an essential role in gene expression regulation and therefore is under selective constraint. Interestingly, the PNMT intronic GRE was surrounded by multiple potential IREs. There are multiple examples of genes (IGFBP-1, TAT, AAT, PEPCK, PFK-2) stimulated by glucocorticoids and inhibited by insulin in liver [35]. To our knowledge, insulin responsiveness has not been studied for rat or bovine Pnmt promoters. But already years ago it was shown that PNMT activity was approximately 2-fold higher in the brainstem of streptozotocin-induced diabetic rats than in controls, and the administration of insulin partially prevented the effects of diabetes on PNMT activity [51]. In the adrenal medulla of rats, PNMT mRNA levels were increased as a response to a single administration of insulin 5I U [52]. A recent study using diabetic rats confirmed a protective effect of insulin treatment on PNMT levels and counter regulation [53] of epinephrine.
###end p 53
###begin p 54
###xml 124 149 124 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6-phosphofructo-2-kinase </italic>
###xml 150 155 150 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pfk-2</italic>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 261 265 261 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 375 380 375 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 566 568 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 591 593 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 114 117 <span type="species:ncbi:10116">rat</span>
###xml 250 255 <span type="species:ncbi:10090">mouse</span>
###xml 437 441 <span type="species:ncbi:10090">mice</span>
###xml 725 729 <span type="species:ncbi:10116">rats</span>
The location of gene regulatory elements within intronic regions is not unique. For example, the first intron for rat liver 6-phosphofructo-2-kinase (Pfk-2) gene harbours GRU targeted by both glucocorticoids and insulin [35] and the transcription of mouse c-HA-ras gene is jointly regulated by a GRE and ERE (Estrogen Responsive Element) [54] similarly to the prediction for PNMT intron 1 GRU. It has been reported that ERbeta-deficient mice develop sustained systolic and diastolic hypertension by 5 months of age and males have higher blood pressure than females [55]. Consistently, Peng [56] showed that estrogen depletion increases blood pressure and hypothalamic norepinephrine in middle-aged spontaneously hypertensive rats.
###end p 54
###begin p 55
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 190 195 190 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 325 327 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 452 454 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 637 639 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 330 338 <span type="species:ncbi:9606">Patients</span>
It has been shown that the levels of epinephrine/norepinephrine (greatly regulated by PNMT enzyme) and also cortisol (the most abundant GC) exhibit circadian fluctuation [43]. Consistently, PNMT intron 1 GRU harbors potential binding sites for transcription factors regulating mammalian circadian clocks, RORalpha and E4BP4 [41]. Patients with essential hypertension have disturbed autonomic cardiovascular regulation and circadian pacemaker function [57]. It has been suggested that a changed suprachiasmatic nucleus (SCN), the mammalian central 'clock' within the hypothalamus in the brain, may precede the development of hypertension[58].
###end p 55
###begin title 56
Conclusion
###end title 56
###begin p 57
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 115 120 115 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 422 427 422 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 437 447 437 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In silico </italic>
###xml 516 521 516 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 581 586 581 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 746 748 746 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 27 32 <span type="species:ncbi:9606">human</span>
###xml 326 331 <span type="species:ncbi:9606">human</span>
###xml 510 515 <span type="species:ncbi:9606">human</span>
###xml 735 740 <span type="species:ncbi:9606">human</span>
We report low diversity of human PNMT gene consistent with purifying selection. We suggest that the differences in PNMT expression between normotensives and hypertensives are not determined by the polymorphisms in this gene, but rather by the interplay of gene expression regulators, which may vary among individuals. A major human-specific gene regulatory unit, Glucocorticoid Responsive Unit (GRU), was predicted within PNMT intron 1. In silico analysis paves the way for the further experimental studies on human PNMT transcription regulation. Understanding the determinants of PNMT expression may assist in developing PNMT inhibitors as potential novel therapeutics, facilitated by recent determination of the crystal structure of human PNMT[46].
###end p 57
###begin title 58
Competing interests
###end title 58
###begin p 59
The author(s) declare that they have no competing interests.
###end p 59
###begin title 60
Authors' contributions
###end title 60
###begin p 61
###xml 202 210 <span type="species:ncbi:9606">patients</span>
KK designed the study, performed resequencing, and contributed to the analysis and interpretation of the data as well as to the writing of the manuscript. MO, MV and VK recruited essential hypertension patients, collected relevant clinical and epidemiological data, and revised the manuscript since its early versions. PJ assisted in collection of normotensive individuals, preparation of the DNA samples and laboratory experiments. ML contributed in outlining the study design and directing research, participated in the data analysis and drafted the manuscript. All authors read and approved the final manuscript.
###end p 61
###begin title 62
Pre-publication history
###end title 62
###begin p 63
The pre-publication history for this paper can be accessed here:
###end p 63
###begin p 64

###end p 64
###begin title 65
Supplementary Material
###end title 65
###begin title 66
Additional file 1
###end title 66
###begin p 67
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pnmt </italic>
###xml 295 300 295 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 380 394 380 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AluSp element </italic>
###xml 614 619 614 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pnmt </italic>
###xml 651 652 651 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 653 655 653 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 673 681 673 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">italics </italic>
###xml 750 755 750 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PNMT </italic>
###xml 756 758 756 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 759 761 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 33 38 <span type="species:ncbi:9606">human</span>
###xml 48 51 <span type="species:ncbi:10116">rat</span>
###xml 223 228 <span type="species:ncbi:9606">human</span>
###xml 233 236 <span type="species:ncbi:10116">rat</span>
###xml 365 370 <span type="species:ncbi:9606">human</span>
###xml 610 613 <span type="species:ncbi:10116">rat</span>
###xml 744 749 <span type="species:ncbi:9606">human</span>
Nucleotide sequence alignment of human PNMT and rat Pnmt genes. Exons of the gene are boxed. mRNA start site is marked with +1. Translation start site is indicated by ATG (red/bold) and red arrow; translation end sites for human and rat are in purple/bold. Seven SNPs identified by resequencing PNMT in this study are marked bold with grey shading. The sequence of human-specific AluSp element in the first intron is marked in italics and its start/end sites are indicated by black arrows. Sequences of regulatory elements and transcription factor binding sites (TFBS) are underlined. Experimentally confirmed rat Pnmt expression regulating elements [6,59-62] are typed in italics on green shading background. Predicted regulatory elements for human PNMT [12,13] are typed with regular font (no shading).
###end p 67
###begin p 68
Click here for file
###end p 68
###begin title 69
Acknowledgements
###end title 69
###begin p 70
We thank Dr. Bohumila Janosikova for technical assistance. M.L. and V.K. are a Wellcome Trust International Senior Research Fellows (grants no. 070191/Z/03/Z and 070255/Z/03/Z) in Biomedical Science in Central Europe, M.L. is a HHMI International Scholar (grant #55005617). Additionally, the study has been supported by Estonian Ministry of Education and Science core grant no. 0182721s06 and Estonian Science Foundation grant no. 5796 (M.L., K.K., P.J.), and travel-stipend from Kristjan-Jaak foundation (K.K.).
###end p 70
###begin article-title 71
###xml 12 17 <span type="species:ncbi:9606">human</span>
Genetics of human arterial hypertension
###end article-title 71
###begin article-title 72
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human chromosome 17 in essential hypertension
###end article-title 72
###begin article-title 73
###xml 109 113 <span type="species:ncbi:10116">rats</span>
Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats
###end article-title 73
###begin article-title 74
###xml 27 32 <span type="species:ncbi:9606">human</span>
###xml 120 123 <span type="species:ncbi:10116">rat</span>
Genetic susceptibility for human familial essential hypertension in a region of homology with blood pressure linkage on rat chromosome 10
###end article-title 74
###begin article-title 75
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human hypertension caused by mutations in WNK kinases
###end article-title 75
###begin article-title 76
Location, development, control, and function of extraadrenal phenylethanolamine N-methyltransferase
###end article-title 76
###begin article-title 77
Phaeochromocytoma
###end article-title 77
###begin article-title 78
Adrenaline-forming enzyme in brainstem: elevation in genetics and experimental hypertension
###end article-title 78
###begin article-title 79
###xml 73 76 <span type="species:ncbi:10116">SHR</span>
Catecholamine-Releated Gene Expression Correlates With Blood Pressure in SHR
###end article-title 79
###begin article-title 80
Investigation of the phenylethanolamine N-methyltransferase gene as a candidate gene for hypertension
###end article-title 80
###begin article-title 81
Determinants of phenylethanolamine-N-methyltransferase expression
###end article-title 81
###begin article-title 82
###xml 0 15 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 28 33 <span type="species:ncbi:9606">human</span>
Transgenic mice express the human phenylethanolamine N-methyltransferase gene in adrenal medulla and retina
###end article-title 82
###begin article-title 83
###xml 13 18 <span type="species:ncbi:9606">human</span>
Structure of human phenylethanolamine N-methyltransferase gene: existence of two types of mRNA with different transcription initiation sites
###end article-title 83
###begin article-title 84
Association of polymorphisms in the promoter region of the PNMT gene with essential hypertension in African Americans but not in whites
###end article-title 84
###begin article-title 85
Genetic variants of homocysteine metabolizing enzymes and the risk of coronary artery disease
###end article-title 85
###begin article-title 86
National Centre for Biotechnology Information (NCBI)
###end article-title 86
###begin article-title 87
Primer3 Software
###end article-title 87
###begin article-title 88
National Centre for Biotechnology Information (NCBI BLAST)
###end article-title 88
###begin article-title 89
###xml 44 49 <span type="species:ncbi:9606">Human</span>
Segmental duplications and gene conversion: Human luteinizing hormone/chorionic gonadotropin beta gene cluster
###end article-title 89
###begin article-title 90
Genepop on the web
###end article-title 90
###begin article-title 91
PHASE: software for haplotype reconstruction, and recombination rate estimation from population data
###end article-title 91
###begin article-title 92
DnaSP: DNA Sequence Polymorphism software
###end article-title 92
###begin article-title 93
On the number of segregating sites in genetical models without recombination
###end article-title 93
###begin article-title 94
Statistical method for testing the neutral mutation hypothesis by DNA polymorphism
###end article-title 94
###begin article-title 95
Genomatix company webpage
###end article-title 95
###begin article-title 96
MatInspector and beyond: promoter analysis based on transcription factor binding sites
###end article-title 96
###begin article-title 97
BIOBASE: Biological Databases
###end article-title 97
###begin article-title 98
Institute for System Biology, RepeatMasker Web Server
###end article-title 98
###begin article-title 99
###xml 80 85 <span type="species:ncbi:9606">human</span>
Evidence for substantial fine-scale variation in recombination rates across the human genome
###end article-title 99
###begin article-title 100
Mechanisms of glucocorticoid signalling
###end article-title 100
###begin article-title 101
Phenylethanolamine N-methyltransferase gene expression: synergistic activation by Egr-1, AP-2 and the glucocorticoid receptor
###end article-title 101
###begin article-title 102
Phenylethanolamine N-methyltransferase gene expression. Sp1 and MAZ potential for tissue-specific expression
###end article-title 102
###begin article-title 103
###xml 140 146 <span type="species:ncbi:9913">bovine</span>
Three zinc finger nuclear proteins, Sp1, Sp3, and a ZBP-89 homologue, bind to the cyclic adenosine monophosphate-responsive sequence of the bovine adrenodoxin gene and regulate transcription
###end article-title 103
###begin article-title 104
Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids
###end article-title 104
###begin article-title 105
Insulin inhibition of glucocorticoid-stimulated gene transcription: requirement for an insulin response element?
###end article-title 105
###begin article-title 106
HMGI/Y proteins: flexible regulators of transcription and chromatin structure
###end article-title 106
###begin article-title 107
###xml 81 87 <span type="species:ncbi:9606">humans</span>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice
###end article-title 107
###begin article-title 108
A novel glucocorticoid regulatory unit mediates the hormone responsiveness of the beta1-adrenergic receptor gene
###end article-title 108
###begin article-title 109
The role of proximal-enhancer elements in the glucocorticoid regulation of carbamoylphosphate synthetase gene transcription from the upstream response unit
###end article-title 109
###begin article-title 110
Anatomy of the estrogen response element
###end article-title 110
###begin article-title 111
System-level identification of transcriptional circuits underlying mammalian circadian clocks
###end article-title 111
###begin article-title 112
E4BP4/NFIL3, a PAR-related bZIP factor with many roles
###end article-title 112
###begin article-title 113
###xml 98 103 <span type="species:ncbi:9606">women</span>
Seasonal and biological variation of urinary epinephrine, norepinephrine, and cortisol in healthy women
###end article-title 113
###begin article-title 114
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human phenylethanolamine N-methyltransferase pharmacogenomics: gene re-sequencing and functional genomics
###end article-title 114
###begin article-title 115
Cholinergic and peptidergic regulation of phenylethanolamine N-methyltransferase gene expression
###end article-title 115
###begin article-title 116
Getting the adrenaline going: crystal structure of the adrenaline-synthesizing enzyme PNMT
###end article-title 116
###begin article-title 117
Phenylethanolamine N-methyltransferase (PNMT) gene and early-onset Alzheimer disease
###end article-title 117
###begin article-title 118
Association between the phenylethanolamine N-methyltransferase gene and multiple sclerosis
###end article-title 118
###begin article-title 119
DNA sequence insertion and evolutionary variation in gene regulation
###end article-title 119
###begin article-title 120
###xml 111 117 <span type="species:ncbi:9913">bovine</span>
Differential regulation of phenylethanolamine N-methyltransferase expression in two distinct subpopulations of bovine chromaffin cells
###end article-title 120
###begin article-title 121
###xml 80 84 <span type="species:ncbi:10116">rats</span>
Phenylethanolamine N-methyltransferase in the brains of streptozotocin diabetic rats
###end article-title 121
###begin article-title 122
###xml 102 106 <span type="species:ncbi:10116">rats</span>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
Localization and regulation of phenylethanolamine N-methyltransferase gene expression in the heart of rats and mice during stress
###end article-title 122
###begin article-title 123
###xml 162 166 <span type="species:ncbi:10116">Rats</span>
Effects of Insulin Treatment without and with Recurrent Hypoglycemia on Hypoglycemic Counterregulation and Adrenal Catecholamine-Synthesizing Enzymes in Diabetic Rats
###end article-title 123
###begin article-title 124
Estrogen inducibility of c-Ha-ras transcription in breast cancer cells. Identification of functional estrogen-responsive transcriptional regulatory elements in exon 1/intron 1 of the c-Ha-ras gene
###end article-title 124
###begin article-title 125
###xml 47 51 <span type="species:ncbi:10090">mice</span>
Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta
###end article-title 125
###begin article-title 126
###xml 118 122 <span type="species:ncbi:10116">rats</span>
Estrogen depletion increases blood pressure and hypothalamic norepinephrine in middle-aged spontaneously hypertensive rats
###end article-title 126
###begin article-title 127
Altered pattern of circadian neural control of heart period in mild hypertension
###end article-title 127
###begin article-title 128
The biological clock tunes the organs of the body: timing by hormones and the autonomic nervous system
###end article-title 128
###begin article-title 129
Nicotine stimulates expression of the PNMT gene through a novel promoter sequence
###end article-title 129
###begin article-title 130
###xml 18 21 <span type="species:ncbi:10116">rat</span>
Regulation of the rat phenylethanolamine N-methyltransferase gene by transcription factors Sp1 and MAZ
###end article-title 130
###begin article-title 131
Phenylethanolamine N-methyltransferase gene regulation by cAMP-dependent protein kinase A and protein kinase C signaling pathways
###end article-title 131
###begin article-title 132
Protein kinase A and protein kinase C signaling pathway interaction in phenylethanolamine N-methyltransferase gene regulation
###end article-title 132

